|
Quan Liu, M.D., Ph.D., (born in 1974 in Tianjin, China) is currently a neuroscientist in University of California, San Diego (UCSD). Dr. Liu is recognized in the field of Alzheimer's disease (AD), aging, and Glaucoma research particularly for his work related with oxidative stress. Biography Quan Liu finished his medical school training in Tianjin Medical University (TMU) in 1997, and his Ph.D. in the laboratories of Dr. George Perry in Department of Pathology at Case Western Reserve University (CWRU) from 2001 to 2005. He was a research scientist in the Department of Cell Biology in the laboratories of Dr. Roy L. Silverstein at Cleveland Clinic Foundation (CCF), Cleveland Ohio. Dr. Liu is currently a senior research scientist in the laboratories of Dr. Robert N. Weinreb. Dr. Weinreb is the Director of the Hamilton Glaucoma Center at the Shiley Eye Center in the School of Medicine and the Medical Center at the University of California, San Diego. Dr. Liu has published more than 50 peer-reviewed research papers, commentaries, and conference abstracts. He has been invited for multiple lectures. He is married with Fang Xie, M.D., Ph.D., who is currently a neuroscientist in University of California, San Diego. They have a baby boy named Kingston A. Liu born in Sep 2007. Research focus Quan Liu's research is primarily focused on the mechanism of neurodegeneration and development of new prevention or therapies for neurodegenerative diseases such as Alzheimer disease and Glaucoma. He has played a key role in elucidating oxidative damage as the initial abnormality in Alzheimer disease and Glaucoma. His current studies focus on testing different agents in mouse models of neurodegenerative diseases, such as Resveratrol. Others Quan Liu is editor or reviewer for more than 30 scientific journals. He has multiple awards for his contribution in neurodegenerative diseases research. His research work has been reported in numerous prestigious media, such as EurekAlert!, which is an online, global news service operated by American Association for the Advancement of Science (AAAS), the Science publisher. His most recent research work was also reported by multiple news media, such as Ophthalmology Times, Modern Medicine.
|
|
|